This new blue pill is stopping HIV like never before: LANCET
An anti-viral pill cut new HIV cases among men by almost a third to the lowest on record, study published in Lancet shows.

New cases of HIV among gay and bisexual men fell by almost a third to the lowest on record, according to the world’s first study to measure the impact of Gilead Sciences Inc.’s Truvada pill on reducing the AIDS-causing virus in a large population.

These results may pave the way for other states and countries to stop transmission of the virus with the use of a treatment called pre-exposure prophylaxis, or PrEP.

The blue, oval-shaped pill is a fixed-dose combination of the drugs tenofovir, disoproxil and emtricitabine. Generic versions of Truvada made by Mylan NV, Cipla Ltd. and Teva Pharmaceutical Industries Ltd. have made the medication available more cheaply.

Read more here: https://theprint.in/economy/this-new-blue-pill-is-stopping-hiv-like-never-before-study-shows/136379/
A●●●●●p N●g and 3 others like this
Like
Comment
Share